What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women

Depression and Anxiety

Volumn 26, Issue 8, 2009, Pages 724-731

  Feeny, Norah C ^a   Zoellner, Lori A ^b   Mavissakalian, Matig R ^a   Roy Byrne, Peter P ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Choice; Prolonged exposure; PTSD; Sertraline

Indexed keywords

SERTRALINE;

ADULT; AGED; ARTICLE; ASSAULT; AUTOREGULATION; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ETHNICITY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PATIENT DECISION MAKING; POSTTRAUMATIC STRESS DISORDER; PREGNANCY TEST; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SEXUAL CRIME; STATE TRAIT ANXIETY INVENTORY; THERAPY EFFECT; TREATMENT OUTCOME; URINALYSIS;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CHOICE BEHAVIOR; CHRONIC DISEASE; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMPLOSIVE THERAPY; INTERVIEW, PSYCHOLOGICAL; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; PERSONALITY INVENTORY; PSYCHOMETRICS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 68149153232     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20588     Document Type: Article

References (36)

1. Bradley R, Greene J, Russ E, et al. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry 2005;162:214-227.
2. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of Zoloft treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 2000;283:1837-1844. (Pubitemid 30207620)
3. Davidson JRT, Rothbaum BO, van der Kolk B, et al. Multicenter, double blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001;58:475-485.
4. Institute of Medicine of the National Academies. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington, DC: The National Academies Press; 2007.
5. Frommberger U, Stieglitz RD, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int J Psychiatry Clin Pract 2004;8:19-23. (Pubitemid 38332454)
6. van der kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry 2007;68:37-46.
7. Pitman RK, Altman B, Greenwald E, et al. Psychiatric complications during flooding therapy for posttraumatic stress disorder. J Clin Psychiatry 1991;52:17-20.
8. Scott MJ, Stradling SG. Client compliance with exposure treatments for posttraumatic stress disorder. J Traum Stress 1997;10:523-526. (Pubitemid 27316415)
9. Street LL, Niederehe G, Lebowitz BD. Toward greater public health relevance for psychotherapeutic intervention research: an NIMH workshop report. Clin Psychol Sci Pract 2000;7:127-137.
10. Becker CB, Darius E, Schaumberg K. An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder. Behav Ther 2007;45:2861-2873. (Pubitemid 350007433)
11. Roy-Byrne P, Berliner L, Russo J, et al. Treatment preferences and determinants in victims of sexual and physical assault. J Nerv Ment Dis 2003;191:161-165. (Pubitemid 36323956)
12. Tarrier N, Liversidge T, Gregg L. The acceptability and preference for the psychological treatment of PTSD. Behav Res Ther 2006;44:1643-1656. (Pubitemid 44442151)
13. Zoellner LA, Feeny NC, Cochran B, Pruitt L. Treatment choice for PTSD. Behav Res Ther 2003;41:879-886.
14. Microsoft Inc., 2000.
15. Foa EB, Cashman L, Jaycox LH, Perry K. The validation of a self-report measure of PTSD: the PTSD diagnostic scale. Psychol Assess 1997;9:445-451.
16. Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress 1993;6:459-473.
17. Beck AT, Ward CH, Mendelsohn M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
18. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
19. Spitzer RL,Williams JBW, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID I): history, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
20. Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment of chronic PTSD: a fixed dosage, multicenter placebo-controlled study. Am J Psychiatry 2001;158:1982-1988. (Pubitemid 33104102)
21. Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol 2005;73:953-964.
22. McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 2004;9:403-425. (Pubitemid 40005040)
23. Angelo FN, Miller HE, Zoellner LA, et al. I need to talk about it: a qualitative analysis of trauma-exposed women's reasons for treatment choice. Behav Ther 2008;39:13-21.
24. Cochran BN, Pruitt L, Fukuda S, et al. Reasons underlying treatment preference: an exploratory study. J Interpers Violence 2008;23:276-291.
25. Tabachnick BG, Fidell LS. Using multivariate statistics. New York: Harper Collins; 1996.
26. Jaccard J, Guilamo-Ramos J. Analysis of variance frameworks in clinical child and adolescent psychology: issues and recommendations. J Clin Child Adolesc Psychol 2002a;31:130-146. (Pubitemid 37110147)
27. Jaccard J, Guilamo-Ramos J. Analysis of variance frameworks in clinical child and adolescent psychology: advanced issues and recommendations. J Clin Child Adolesc Psychol 2002b;31:278-294. (Pubitemid 37110264)
28. Holm S. A simple sequentially rejective multiple test procedure. Scan J Stat 1979;6:65-70.
29. Cloitre M, Koenen KC, Cohen LR, Han H. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol 2002;70:1067-1074.
30. Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol 2002;70:867-879. (Pubitemid 34851272)
31. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-1060.
32. Hazlett-Stevens H, Craske MG, Roy-Byrne PP, et al. Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients. Gen Hosp Psychiatry 2002;24:316-321. (Pubitemid 36151667)
33. Londborg PD, Hegel MT, Goldstein S, et al. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. J Clin Psychiatry 2001;62:325-331. (Pubitemid 32545552)
34. DeSteno D, Salovey P. Jealousy and the characteristics of one's rival: a self evaluation maintenance perspective. Pers Soc Psychol Bull 1996;9:920-932. (Pubitemid 126126259)
35. Pyne JM, Rost KM, Farahati F, et al. One size fits some: the impact of patient treatment attitudes on the cost effectiveness of a depression primary care intervention. Psychol Med 2005;35:839-854. (Pubitemid 40873384)
36. Chilvers C, Dewey M, Fielding K, et al. Antidepressant drugs and generic counseling for treatment of major depression in primary care: Randomised trial with patient preference arms. Br Med J 2001;322:772-775. (Pubitemid 32269653)